Circulating microRNAs and bioinformatics tools to discover novel diagnostic biomarkers of pediatric diseases

Genes

Volumn 8, Issue 9, 2017, Pages

  Baldassarre, Antonella ^a   Felli, Cristina ^a   Prantera, Giorgio ^b   Masotti, Andrea ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Bioinformatics tools; Biomarkers; Body fluids; Circulating microRNAs; Pediatric diseases

Indexed keywords

MICRORNA; RNA BINDING PROTEIN; SMALL UNTRANSLATED RNA;

ACCESS TO INFORMATION; AUTISM; BILE DUCT ATRESIA; BIOINFORMATICS; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; DISEASE MARKER; EWING SARCOMA; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC TRANSCRIPTION; HEPATITIS B; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERNET; LIVER DISEASE; MEMBRANE VESICLE; NEPHROBLASTOMA; NEPHROTIC SYNDROME; NEXT GENERATION SEQUENCING; NON INVASIVE MEASUREMENT; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; RNA ANALYSIS; RNA STABILITY;

EID: 85029147491     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes8090234     Document Type: Review

References (160)

1. Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233. [CrossRef] [PubMed]
2. Carthew, R.W.; Sontheimer, E.J. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136, 642–655. [CrossRef] [PubMed]
3. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75, 843–854. [CrossRef]
4. Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75, 855–862. [CrossRef]
5. Kosaka, N.; Iguchi, H.; Ochiya, T. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer. Sci. 2010, 101, 2087–2092. [CrossRef] [PubMed]
6. Chim, S.S.; Shing, T.K.; Hung, E.C.; Leung, T.Y.; Lau, T.K.; Chiu, R.W.; Lo, Y.M. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 2008, 54, 482–490. [CrossRef] [PubMed]
7. Chen, Y.; Gelfond, J.A.; McManus, L.M.; Shireman, P.K. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genom. 2009, 10, 407. [CrossRef] [PubMed]
8. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O’Briant, K.C.; Allen, A., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513–10518. [CrossRef] [PubMed]
9. Cortez, M.A.; Bueso-Ramos, C.; Ferdin, J.; Lopez-Berestein, G.; Sood, A.K.; Calin, G.A. MicroRNAs in body fluids—the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8, 467–477. [CrossRef] [PubMed]
10. Jones, M.R.; Quinton, L.J.; Blahna, M.T.; Neilson, J.R.; Fu, S.; Ivanov, A.R.; Wolf, D.A.; Mizgerd, J.P. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 2009, 11, 1157–1163. [CrossRef] [PubMed]
11. Katoh, T.; Sakaguchi, Y.; Miyauchi, K.; Suzuki, T.; Kashiwabara, S.; Baba, T.; Suzuki, T. Selective stabilization of mammalian microRNAs by 3’ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 2009, 23, 433–438. [CrossRef] [PubMed]
12. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659. [CrossRef] [PubMed]
13. Kosaka, N.; Iguchi, H.; Yoshioka, Y.; Takeshita, F.; Matsuki, Y.; Ochiya, T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285, 17442–17452. [CrossRef] [PubMed]
14. Hu, Z.; Chen, X.; Zhao, Y.; Tian, T.; Jin, G.; Shu, Y.; Chen, Y.; Xu, L.; Zen, K.; Zhang, C., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 2010, 28, 1721–1726. [CrossRef] [PubMed]
15. Gibbings, D.J.; Ciaudo, C.; Erhardt, M.; Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 2009, 11, 1143–1149. [CrossRef] [PubMed]
16. Vickers, K.C.; Palmisano, B.T.; Shoucri, B.M.; Shamburek, R.D.; Remaley, A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13, 423–433. [CrossRef] [PubMed]
17. Bala, S.; Petrasek, J.; Mundkur, S.; Catalano, D.; Levin, I.; Ward, J.; Alao, H.; Kodys, K.; Szabo, G. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56, 1946–1957. [CrossRef] [PubMed]
18. Medzhitov, R.; Janeway, C., Jr. Innate immune recognition: Mechanisms and pathways. Immunol. Rev. 2000, 173, 89–97. [CrossRef] [PubMed]
19. Heil, F.; Hemmi, H.; Hochrein, H.; Ampenberger, F.; Kirschning, C.; Akira, S.; Lipford, G.; Wagner, H.; Bauer, S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303, 1526–1529. [CrossRef] [PubMed]
20. Fabbri, M. TLRs as miRNA receptors. Cancer Res. 2012, 72, 6333–6337. [CrossRef] [PubMed]
21. Lehmann, S.M.; Krüger, C.; Park, B.; Derkow, K.; Rosenberger, K.; Baumgart, J.; Trimbuch, T.; Eom, G.; Hinz, M.; Kaul, D., et al. An unconventional role for miRNA: Let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 2012, 15, 827–835. [CrossRef] [PubMed]
22. Fabbri, M.; Paone, A.; Calore, F.; Galli, R.; Gaudio, E.; Santhanam, R.; Lovat, F.; Fadda, P.; Mao, C.; Nuovo, G.J., et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. USA 2012, 109, E2110–E2116. [CrossRef] [PubMed]
23. Etheridge, A.; Lee, I.; Hood, L.; Galas, D.; Wang, K. Extracellular microRNA: A new source of biomarkers. Mutat. Res. 2011, 717, 85–90. [CrossRef] [PubMed]
24. Huang, Z.; Huang, D.; Ni, S.; Peng, Z.; Sheng, W.; Du, X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127, 118–126. [CrossRef] [PubMed]
25. Park, N.J.; Zhou, H.; Elashoff, D.; Henson, B.S.; Kastratovic, D.A.; Abemayor, E.; Wong, D.T. Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15, 5473–5477. [CrossRef] [PubMed]
26. Corsten, M.F.; Dennert, R.; Jochems, S.; Kuznetsova, T.; Devaux, Y.; Hofstra, L.; Wagner, D.R.; Staessen, J.A.; Heymans, S.; Schroen, B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 2010, 3, 499–506. [CrossRef] [PubMed]
27. Lodes, M.J.; Caraballo, M.; Suciu, D.; Munro, S.; Kumar, A.; Anderson, B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 2009, 4, e6229. [CrossRef] [PubMed]
28. Resnick, K.E.; Alder, H.; Hagan, J.P.; Richardson, D.L.; Croce, C.M.; Cohn, D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 2009, 112, 55–59. [CrossRef] [PubMed]
29. Chen, C.; Ridzon, D.A.; Broomer, A.J.; Zhou, Z.; Lee, D.H.; Nguyen, J.T.; Barbisin, M.; Xu, N.L.; Mahuvakar, V.R.; Andersen, M.R., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33, e179. [CrossRef] [PubMed]
30. Schamberger, A.; Orban, T.I. 3’ IsomiR species and DNA contamination influence reliable quantification of microRNAs by stem-loop quantitative PCR. PLoS ONE 2014, 9, e106315. [CrossRef] [PubMed]
31. Schuster, S.C. Next-generation sequencing transforms today’s biology. Nat. Methods 2008, 5, 16–18. [CrossRef] [PubMed]
32. Wach, S.; Nolte, E.; Szczyrba, J.; Stohr, R.; Hartmann, A.; Orntoft, T.; Dyrskjot, L.; Eltze, E.; Wieland, W.; Keck, B., et al. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int. J. Cancer 2012, 130, 611–621. [CrossRef] [PubMed]
33. Han, Y.; Chen, J.; Zhao, X.; Liang, C.; Wang, Y.; Sun, L.; Jiang, Z.; Zhang, Z.; Yang, R.; Chen, J., et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 2011, 6, e18286. [CrossRef] [PubMed]
34. Williams, Z.; Ben-Dov, I.Z.; Elias, R.; Mihailovic, A.; Brown, M.; Rosenwaks, Z.; Tuschl, T. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc. Natl. Acad. Sci. USA 2013, 110, 4255–4260. [CrossRef] [PubMed]
35. Bellingham, S.A.; Coleman, B.M.; Hill, A.F. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012, 40, 10937–10949. [CrossRef] [PubMed]
36. Wu, X.; Somlo, G.; Yu, Y.; Palomares, M.R.; Li, A.X.; Zhou, W.; Chow, A.; Ye, Y.; Rossi, J.J.; Gao, H.; Wang, J., et al. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J. Transl. Med. 2012, 10, 42. [CrossRef] [PubMed]
37. Mestdagh, P.; Hartmann, N.; Baeriswyl, L.; Andreasen, D.; Bernard, N.; Chen, C.; Cheo, D.; D'Andrade, P.; DeMayo, M.; Dennis, L.; Derveaux, S., et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat. Methods 2014, 11, 809–815. [CrossRef] [PubMed]
38. Cheng, H.H.; Yi, H.S.; Kim, Y.; Kroh, E.M.; Chien, J.W.; Eaton, K.D.; Goodman, M.T.; Tait, J.F.; Tewari, M.; Pritchard, C.C. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS ONE 2013, 8, e64795. [CrossRef] [PubMed]
39. McAlexander, M.A.; Phillips, M.J.; Witwer, K.W. Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid. Front. Genet. 2013, 4, 83. [CrossRef] [PubMed]
40. D’haene, B.; Mestdagh, P.; Hellemans, J.; Vandesompele, J. miRNA expression profiling: From reference genes to global mean normalization. Methods Mol. Biol. 2012, 822, 261–272. [PubMed]
41. Luo, S.S.; Ishibashi, O.; Ishikawa, G.; Ishikawa, T.; Katayama, A.; Mishima, T.; Takizawa, T.; Shigihara, T.; Goto, T.; Izumi, A., et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol. Reprod. 2009, 81, 717–729. [CrossRef] [PubMed]
42. Lardizabal, M.N.; Nocito, A.L.; Daniele, S.M.; Ornella, L.A.; Palatnik, J.F.; Veggi, L.M. Reference genes for real-time PCR quantification of microRNAs and messenger RNAs in rat models of hepatotoxicity. PLoS ONE 2012, 7, e36323. [CrossRef] [PubMed]
43. Wang, R.; Li, N.; Zhang, Y.; Ran, Y.; Pu, J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern. Med. 2011, 50, 1789–1795. [CrossRef] [PubMed]
44. Hunter, M.P.; Ismail, N.; Zhang, X.; Aguda, B.D.; Lee, E.J.; Yu, L.; Xiao, T.; Schafer, J.; Lee, M.L.; Schmittgen, T.D., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3, e3694. [CrossRef] [PubMed]
45. Ho, A.S.; Huang, X.; Cao, H.; Christman-Skieller, C.; Bennewith, K.; Le, Q.T.; Koong, A.C. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Transl. Oncol. 2010, 3, 109–113. [CrossRef] [PubMed]
46. Zhu, W.; Qin, W.; Atasoy, U.; Sauter, E.R. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2009, 2, 89. [CrossRef] [PubMed]
47. Zhao, H.; Shen, J.; Medico, L.; Wang, D.; Ambrosone, C.B.; Liu, S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 2010, 5, e13735. [CrossRef] [PubMed]
48. Roth, C.; Rack, B.; Muller, V.; Janni, W.; Pantel, K.; Schwarzenbach, H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res. 2010, 12, R90. [CrossRef] [PubMed]
49. Qu, K.Z.; Zhang, K.; Li, H.; Afdhal, N.H.; Albitar, M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J. Clin. Gastroenterol. 2011, 45, 355–360. [CrossRef] [PubMed]
50. Yamada, A.; Cox, M.A.; Gaffney, K.A.; Moreland, A.; Boland, C.R.; Goel, A. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS ONE 2014, 9, e112481. [CrossRef] [PubMed]
51. Mestdagh, P.; Van Vlierberghe, P.; DeWeer, A.; Muth, D.; Westermann, F.; Speleman, F.; Vandesompele, J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10, R64. [CrossRef] [PubMed]
52. Vigneron, N. Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy. Mol. Oncol. 2016, 10, 981–992. [CrossRef] [PubMed]
53. Gilad, S.; Meiri, E.; Yogev, Y.; Benjamin, S.; Lebanony, D.; Yerushalmi, N.; Benjamin, H.; Kushnir, M.; Cholakh, H.; Melamed, N., et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 2008, 3, e3148. [CrossRef] [PubMed]
54. Cortez, M.A.; Calin, G.A. MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9, 703–711. [CrossRef] [PubMed]
55. Hanke, M.; Hoefig, K.; Merz, H.; Feller, A.C.; Kausch, I.; Jocham, D.; Warnecke, J.M.; Sczakiel, G. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 2010, 28, 655–661. [CrossRef] [PubMed]
56. Russo, F.; Bella, S.D.; Nigita, G.; Macca, V.; Lagana, A.; Giugno, R.; Pulvirenti, A.; Ferro, A. miRandola: Extracellular circulating microRNAs database. PLoS ONE 2012, 7, e47786. [CrossRef] [PubMed]
57. Aly, H.; Gottlieb, P. The honeymoon phase: Intersection of metabolism and immunology. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16, 286–292. [CrossRef] [PubMed]
58. Nielsen, L.B.; Wang, C.; Sorensen, K.; Bang-Berthelsen, C.H.; Hansen, L.; Andersen, M.L.; Hougaard, P.; Juul, A.; Zhang, C.Y.; Pociot, F., et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp. Diabetes Res. 2012, 2012, 2012:896362. [PubMed]
59. Erener, S.; Marwaha, A.; Tan, R.; Panagiotopoulos, C.; Kieffer, T.J. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight 2017, 2, e89656. [CrossRef] [PubMed]
60. Bagga, A.; Mantan, M. Nephrotic syndrome in children. Indian J. Med. Res. 2005, 122, 13–28. [PubMed]
61. Boute, N.; Gribouval, O.; Roselli, S.; Benessy, F.; Lee, H.; Fuchshuber, A.; Dahan, K.; Gubler, M.C.; Niaudet, P.; Antignac, C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 2000, 24, 349–354. [PubMed]
62. Li, H.Q.; Wu, J.; Niu, D.M.; Shi, Y.H.; Zhang, C.N.; Wang, J.J. The level of native and oxidized lipoprotein(a) in children with nephrotic syndrome. Clin. Biochem. 2012, 45, 101–105. [CrossRef] [PubMed]
63. Abeyagunawardena, A.S. Treatment of steroid sensitive nephrotic syndrome. Indian J. Pediatr. 2005, 72, 763–769. [CrossRef] [PubMed]
64. Eddy, A.A.; Symons, J.M. Nephrotic syndrome in childhood. Lancet 2003, 362, 629–639. [CrossRef]
65. Wang, G.; Tam, L.S.; Li, E.K.; Kwan, B.C.; Chow, K.M.; Luk, C.C.; Li, P.K.; Szeto, C.C. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2011, 20, 493–500. [CrossRef] [PubMed]
66. Wang, G.; Kwan, B.C.; Lai, F.M.; Chow, K.M.; Li, P.K.; Szeto, C.C. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 2011, 30, 171–179. [CrossRef] [PubMed]
67. Wang, G.; Kwan, B.C.; Lai, F.M.; Chow, K.M.; Li, P.K.; Szeto, C.C. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis. Markers 2010, 28, 79–86. [CrossRef] [PubMed]
68. Lorenzen, J.M.; Kielstein, J.T.; Hafer, C.; Gupta, S.K.; Kumpers, P.; Faulhaber-Walter, R.; Haller, H.; Fliser, D.; Thum, T. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol. 2011, 6, 1540–1546. [CrossRef] [PubMed]
69. Neal, C.S.; Michael, M.Z.; Pimlott, L.K.; Yong, T.Y.; Li, J.Y.; Gleadle, J.M. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol. Dial. Transplant. 2011, 26, 3794–3802. [CrossRef] [PubMed]
70. Luo, Y.; Wang, C.; Chen, X.; Zhong, T.; Cai, X.; Chen, S.; Shi, Y.; Hu, J.; Guan, X.; Xia, Z., et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 2013, 59, 658–666. [CrossRef] [PubMed]
71. Mathieson, P.W. Update on the podocyte. Curr. Opin. Nephrol. Hypertens. 2009, 18, 206–211. [CrossRef] [PubMed]
72. Shi, S.; Yu, L.; Chiu, C.; Sun, Y.; Chen, J.; Khitrov, G.; Merkenschlager, M.; Holzman, L.B.; Zhang, W.; Mundel, P., et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J. Am. Soc. Nephrol. 2008, 19, 2159–2169. [CrossRef] [PubMed]
73. Zhdanova, O.; Srivastava, S.; Di, L.; Li, Z.; Tchelebi, L.; Dworkin, S.; Johnstone, D.B.; Zavadil, J.; Chong, M.M.; Littman, D.R., et al. The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy. Kidney Int. 2011, 80, 719–730. [CrossRef] [PubMed]
74. Harvey, S.J.; Jarad, G.; Cunningham, J.; Goldberg, S.; Schermer, B.; Harfe, B.D.; McManus, M.T.; Benzing, T.; Miner, J.H. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J. Am. Soc. Nephrol. 2008, 19, 2150–2158. [CrossRef] [PubMed]
75. McKenna, L.B.; Schug, J.; Vourekas, A.; McKenna, J.B.; Bramswig, N.C.; Friedman, J.R.; Kaestner, K.H. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010, 139, 1654–1664, 1664.e1. [CrossRef] [PubMed]
76. Masotti, A. Interplays between gut microbiota and gene expression regulation by miRNAs. Front. Cell. Infect. Microbiol. 2012, 2, 137. [CrossRef] [PubMed]
77. Celluzzi, A.; Masotti, A. How Our Other Genome Controls Our Epi-Genome. Trends Microbiol. 2016, 24, 777–787. [CrossRef] [PubMed]
78. Zahm, A.M.; Thayu, M.; Hand, N.J.; Horner, A.; Leonard, M.B.; Friedman, J.R. Circulating microRNA is a biomarker of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 2011, 53, 26–33. [CrossRef] [PubMed]
79. Duttagupta, R.; DiRienzo, S.; Jiang, R.; Bowers, J.; Gollub, J.; Kao, J.; Kearney, K.; Rudolph, D.; Dawany, N.B.; Showe, M.K., et al. Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS ONE 2012, 7, e31241. [CrossRef] [PubMed]
80. Zahm, A.M.; Hand, N.J.; Tsoucas, D.M.; Guen, C.L.L.; Baldassano, R.N.; Friedman, J.R. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon. J. Crohns Colitis 2014, 8, 1108–1117. [CrossRef] [PubMed]
81. Felli, C.; Baldassarre, A.; Masotti, A. Intestinal and Circulating MicroRNAs in Coeliac Disease. Int. J. Mol. Sci. 2017, 18, 1907. [CrossRef] [PubMed]
82. Calle, E.E.; Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer. 2004, 4, 579–591. [CrossRef] [PubMed]
83. Hernando, E. microRNAs and cancer: Role in tumorigenesis, patient classification and therapy. Clin. Transl. Oncol. 2007, 9, 155–160. [CrossRef] [PubMed]
84. Can, U.; Buyukinan, M.; Yerlikaya, F.H. The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity. Pediatr. Obes. 2016, 11, 228–234. [CrossRef] [PubMed]
85. Prats-Puig, A.; Ortega, F.J.; Mercader, J.M.; Moreno-Navarrete, J.M.; Moreno, M.; Bonet, N.; Ricart, W.; Lopez-Bermejo, A.; Fernandez-Real, J.M. Changes in circulating microRNAs are associated with childhood obesity. J. Clin. Endocrinol. Metab. 2013, 98, E1655–E1660. [CrossRef] [PubMed]
86. Masotti, A.; Baldassarre, A.; Fabrizi, M.; Olivero, G.; Loreti, M.C.; Giammaria, P.; Veronelli, P.; Graziani, M.P.; Manco, M. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers. Pediatr. Obes. 2017, 12, 229–238. [CrossRef] [PubMed]
87. Khalyfa, A.; Kheirandish-Gozal, L.; Bhattacharjee, R.; Khalyfa, A.A.; Gozal, D. Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children. Chest 2016, 149, 786–800. [CrossRef] [PubMed]
88. Khalyfa, A.; Kheirandish-Gozal, L.; Gozal, D. Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. Respir. Physiol. Neurobiol. 2017. [PubMed]
89. Persico, A.M.; Napolioni, V. Autism genetics. Behav. Brain Res. 2013, 251, 95–112. [CrossRef] [PubMed]
90. Cristino, A.S.; Williams, S.M.; Hawi, Z.; An, J.Y.; Bellgrove, M.A.; Schwartz, C.E.; Lda, F.C.; Claudianos, C. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol. Psychiatry 2014, 19, 294–301. [CrossRef] [PubMed]
91. Meek, S.E.; Lemery-Chalfant, K.; Jahromi, L.B.; Valiente, C. A review of gene-environment correlations and their implications for autism: A conceptual model. Psychol. Rev. 2013, 120, 497–521. [CrossRef] [PubMed]
92. Miyake, K.; Hirasawa, T.; Koide, T.; Kubota, T. Epigenetics in autism and other neurodevelopmental diseases. Adv. Exp. Med. Biol. 2012, 724, 91–98. [PubMed]
93. Delcuve, G.P.; Rastegar, M.; Davie, J.R. Epigenetic control. J. Cell. Physiol. 2009, 219, 243–250. [CrossRef] [PubMed]
94. Vasu, M.M.; Anitha, A.; Thanseem, I.; Suzuki, K.; Yamada, K.; Takahashi, T.; Wakuda, T.; Iwata, K.; Tsujii, M.; Sugiyama, T., et al. Serum microRNA profiles in children with autism. Mol. Autism 2014, 5, 40. [CrossRef] [PubMed]
95. Leeuwen, L.; Fitzgerald, D.A.; Gaskin, K.J. Liver disease in cystic fibrosis. Paediatr. Respir. Rev. 2014, 15, 69–74. [CrossRef] [PubMed]
96. Lewindon, P.J.; Shepherd, R.W.; Walsh, M.J.; Greer, R.M.; Williamson, R.; Pereira, T.N.; Frawley, K.; Bell, S.C.; Smith, J.L.; Ramm, G.A. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011, 53, 193–201. [CrossRef] [PubMed]
97. Cook, N.L.; Pereira, T.N.; Lewindon, P.J.; Shepherd, R.W.; Ramm, G.A. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2015, 60, 247–254. [CrossRef] [PubMed]
98. Hartley, J.; Harnden, A.; Kelly, D. Biliary atresia. BMJ 2010, 340, 2383. [CrossRef] [PubMed]
99. Zahm, A.M.; Hand, N.J.; Boateng, L.A.; Friedman, J.R. Circulating microRNA is a biomarker of biliary atresia. J. Pediatr. Gastroenterol. Nutr. 2012, 55, 366–369. [CrossRef] [PubMed]
100. Dong, R.; Shen, Z.; Zheng, C.; Chen, G.; Zheng, S. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia. Sci. Rep. 2016, 6, 21084. [CrossRef] [PubMed]
101. Peng, X.; Yang, L.; Liu, H.; Pang, S.; Chen, Y.; Fu, J.; Chen, Y.; Wen, Z.; Zhang, R.; Zhu, B., et al. Identification of Circulating MicroRNAs in Biliary Atresia by Next-Generation Sequencing. J. Pediatr. Gastroenterol. Nutr. 2016, 63, 518–523. [CrossRef] [PubMed]
102. McMahon, B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49, S45–S55. [CrossRef] [PubMed]
103. Lok, A.S.; Heathcote, E.J.; Hoofnagle, J.H. Management of hepatitis B: 2000—Summary of a workshop. Gastroenterology 2001, 120, 1828–1853. [CrossRef] [PubMed]
104. Li, L.M.; Hu, Z.B.; Zhou, Z.X.; Chen, X.; Liu, F.Y.; Zhang, J.F.; Shen, H.B.; Zhang, C.Y.; Zen, K. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 2010, 70, 9798–9807. [CrossRef] [PubMed]
105. Ji, F.; Yang, B.; Peng, X.; Ding, H.; You, H.; Tien, P. Circulating microRNAs in hepatitis B virus-infected patients. J. Viral Hepat. 2011, 18, e242–e251. [CrossRef] [PubMed]
106. Zhou, J.; Yu, L.; Gao, X.; Hu, J.; Wang, J.; Dai, Z.; Wang, J.F.; Zhang, Z.; Lu, S.; Huang, X., et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 2011, 29, 4781–4788. [CrossRef] [PubMed]
107. Winther, T.N.; Bang-Berthelsen, C.H.; Heiberg, I.L.; Pociot, F.; Hogh, B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS ONE 2013, 8, e58236. [CrossRef] [PubMed]
108. Winther, T.N.; Jacobsen, K.S.; Mirza, A.H.; Heiberg, I.L.; Bang-Berthelsen, C.H.; Pociot, F.; Hogh, B. Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes. Int. J. Hepatol. 2014, 2014, 791045. [CrossRef] [PubMed]
109. Winther, T.N.; Heiberg, I.L.; Bang-Berthelsen, C.H.; Pociot, F.; Hogh, B. Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children. PLoS ONE 2013, 8, e80384. [CrossRef] [PubMed]
110. Aggoun, Y.; Bonnet, D.; Sidi, D.; Girardet, J.P.; Brucker, E.; Polak, M.; Safar, M.E.; Levy, B.I. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2070–2075. [CrossRef] [PubMed]
111. Arcaro, G.; Zenere, B.M.; Travia, D.; Zenti, M.G.; Covi, G.; Lechi, A.; Muggeo, M. Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects. Atherosclerosis 1995, 114, 247–254. [CrossRef]
112. Martino, F.; Carlomosti, F.; Avitabile, D.; Persico, L.; Picozza, M.; Barilla, F.; Arca, M.; Montali, A.; Martino, E.; Zanoni, C., et al. Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age. Clin. Sci. 2015, 129, 963–972. [CrossRef] [PubMed]
113. De Carvalho, I.N.; de Freitas, R.M.; Vargas, F.R. Translating microRNAs into biomarkers: What is new for pediatric cancer? Med. Oncol. 2016, 33, 49. [CrossRef] [PubMed]
114. Kline, N.E.; Sevier, N. Solid tumors in children. J. Pediatr. Nurs. 2003, 18, 96–102. [CrossRef] [PubMed]
115. Murray, M.J.; Raby, K.L.; Saini, H.K.; Bailey, S.; Wool, S.V.; Tunnacliffe, J.M.; Enright, A.J.; Nicholson, J.C.; Coleman, N. Solid tumors of childhood display specific serum microRNA profiles. Cancer Epidemiol. Biomarkers Prev. 2015, 24, 350–360. [CrossRef] [PubMed]
116. Miyachi, M.; Tsuchiya, K.; Yoshida, H.; Yagyu, S.; Kikuchi, K.; Misawa, A.; Iehara, T.; Hosoi, H. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 2010, 400, 89–93. [CrossRef] [PubMed]
117. Ouyang, L.; Liu, P.; Yang, S.; Ye, S.; Xu, W.; Liu, X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med. Oncol. 2013, 30, 340. [CrossRef] [PubMed]
118. Tian, Q.; Jia, J.; Ling, S.; Liu, Y.; Yang, S.; Shao, Z. A causal role for circulating miR-34b in osteosarcoma. Eur. J. Surg. Oncol. 2014, 40, 67–72. [CrossRef] [PubMed]
119. Yuan, J.; Chen, L.; Chen, X.; Sun, W.; Zhou, X. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. J. Int. Med. Res. 2012, 40, 2090–2097. [CrossRef] [PubMed]
120. Ma, W.; Zhang, X.; Chai, J.; Chen, P.; Ren, P.; Gong, M. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma. Tumour Biol. 2014, 35, 12467–12472. [CrossRef] [PubMed]
121. Zhang, C.; Yao, C.; Li, H.; Wang, G.; He, X. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int. J. Clin. Exp. Pathol. 2014, 7, 4194–4203. [PubMed]
122. Li, H.; Zhang, K.; Liu, L.H.; Ouyang, Y.; Guo, H.B.; Zhang, H.; Bu, J.; Xiao, T. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncol. Lett. 2015, 10, 1662–1668. [CrossRef] [PubMed]
123. Zhou, G.; Lu, M.; Chen, J.; Li, C.; Zhang, J.; Chen, J.; Shi, X.; Wu, S. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma. Tumour Biol. 2015, 36, 8845–8852. [CrossRef] [PubMed]
124. Lian, F.; Cui, Y.; Zhou, C.; Gao, K.; Wu, L. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma. PLoS ONE 2015, 10, e0121499. [CrossRef] [PubMed]
125. Allen-Rhoades, W.; Kurenbekova, L.; Satterfield, L.; Parikh, N.; Fuja, D.; Shuck, R.L.; Rainusso, N.; Trucco, M.; Barkauskas, D.A.; Jo, E., et al. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma. Cancer Med. 2015, 4, 977–988. [CrossRef] [PubMed]
126. De Vito, C.; Riggi, N.; Suva, M.L.; Janiszewska, M.; Horlbeck, J.; Baumer, K.; Provero, P.; Stamenkovic, I. Let-7a is a direct EWS-FLI-1 target implicated in Ewing’s sarcoma development. PLoS ONE 2011, 6, e23592. [CrossRef] [PubMed]
127. Nie, C.L.; Ren, W.H.; Ma, Y.; Xi, J.S.; Han, B. Circulating miR-125b as a biomarker of Ewing’s sarcoma in Chinese children. Genet. Mol. Res. 2015, 14, 19049–19056. [CrossRef] [PubMed]
128. Golabchi, K.; Soleimani-Jelodar, R.; Aghadoost, N.; Momeni, F.; Moridikia, A.; Nahand, J.S.; Masoudifar, A.; Razmjoo, H.; Mirzaei, H. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers. J. Cell. Physiol. 2017. [CrossRef] [PubMed]
129. Beta, M.; Venkatesan, N.; Vasudevan, M.; Vetrivel, U.; Khetan, V.; Krishnakumar, S. Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets Towards Prediction of Novel Serum Biomarkers. Bioinform. Biol. Insights 2013, 7, 21–34. [PubMed]
130. Liu, S.S.; Wang, Y.S.; Sun, Y.F.; Miao, L.X.; Wang, J.; Li, Y.S.; Liu, H.Y.; Liu, Q.L. Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma. Biomed. Rep. 2014, 2, 424–428. [CrossRef] [PubMed]
131. Schmitt, J.; Backes, C.; Nourkami-Tutdibi, N.; Leidinger, P.; Deutscher, S.; Beier, M.; Gessler, M.; Graf, N.; Lenhof, H.P.; Keller, A., et al. Treatment-independent miRNA signature in blood ofWilms tumor patients. BMC Genom. 2012, 13, 379. [CrossRef] [PubMed]
132. Ludwig, N.; Nourkami-Tutdibi, N.; Backes, C.; Lenhof, H.P.; Graf, N.; Keller, A.; Meese, E. Circulating serum miRNAs as potential biomarkers for nephroblastoma. Pediatr. Blood Cancer 2015, 62, 1360–1367. [CrossRef] [PubMed]
133. Lagana, A.; Forte, S.; Giudice, A.; Arena, M.R.; Puglisi, P.L.; Giugno, R.; Pulvirenti, A.; Shasha, D.; Ferro, A. miRò: A miRNA knowledge base. Database 2009, 2009, bap008. [CrossRef] [PubMed]
134. Mathivanan, S.; Fahner, C.J.; Reid, G.E.; Simpson, R.J. ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40, D1241–D1244. [CrossRef] [PubMed]
135. Kim, D.K.; Lee, J.; Simpson, R.J.; Lotvall, J.; Gho, Y.S. EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin. Cell Dev. Biol. 2015, 40, 4–7. [CrossRef] [PubMed]
136. Benito-Martin, A.; Peinado, H. FunRich proteomics software analysis, let the fun begin! Proteomics 2015, 15, 2555–2556. [CrossRef] [PubMed]
137. Kalra, H.; Simpson, R.J.; Ji, H.; Aikawa, E.; Altevogt, P.; Askenase, P.; Bond, V.C.; Borràs, F.E.; Breakefield, X.; Budnik, V., et al. Vesiclepedia: A compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012, 10, e1001450. [CrossRef] [PubMed]
138. Russo, F.; Bella, S.D.; Bonnici, V.; Lagana, A.; Rainaldi, G.; Pellegrini, M.; Pulvirenti, A.; Giugno, R.; Ferro, A. A knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAs. BMC Genom. 2014, 15 (Suppl. 3), S4. [CrossRef] [PubMed]
139. Moxon, S.; Schwach, F.; Dalmay, T.; Maclean, D.; Studholme, D.J.; Moulton, V. A toolkit for analysing large-scale plant small RNA datasets. Bioinformatics 2008, 24, 2252–2253. [CrossRef] [PubMed]
140. Friedlander, M.R.; Chen, W.; Adamidi, C.; Maaskola, J.; Einspanier, R.; Knespel, S.; Rajewsky, N. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 2008, 26, 407–415. [CrossRef] [PubMed]
141. Friedlander, M.R.; Mackowiak, S.D.; Li, N.; Chen, W.; Rajewsky, N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012, 40, 37–52. [CrossRef] [PubMed]
142. Hackenberg, M.; Sturm, M.; Langenberger, D.; Falcon-Perez, J.M.; Aransay, A.M. miRanalyzer: A microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 2009, 37, W68–W76. [CrossRef] [PubMed]
143. Hackenberg, M.; Rodriguez-Ezpeleta, N.; Aransay, A.M. miRanalyzer: An update on the detection and analysis of microRNAs in high-throughput sequencing experiments. Nucleic Acids Res. 2011, 39, W132–W138. [CrossRef] [PubMed]
144. Pantano, L.; Estivill, X.; Marti, E. SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells. Nucleic Acids Res. 2010, 38, e34. [CrossRef] [PubMed]
145. Fasold, M.; Langenberger, D.; Binder, H.; Stadler, P.F.; Hoffmann, S. DARIO: A ncRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res. 2011, 39, W112–W117. [CrossRef] [PubMed]
146. Stocks, M.B.; Moxon, S.; Mapleson, D.; Woolfenden, H.C.; Mohorianu, I.; Folkes, L.; Schwach, F.; Dalmay, T.; Moulton, V. The UEA sRNA workbench: A suite of tools for analysing and visualizing next generation sequencing microRNA and small RNA datasets. Bioinformatics 2012, 28, 2059–2061. [CrossRef] [PubMed]
147. Axtell, M.J. ShortStack: Comprehensive annotation and quantification of small RNA genes. RNA 2013, 19, 740–751. [CrossRef] [PubMed]
148. Wu, J.; Liu, Q.; Wang, X.; Zheng, J.; Wang, T.; You, M.; Sun, Z.S.; Shi, Q. mirTools 2.0 for non-coding RNA discovery, profiling, and functional annotation based on high-throughput sequencing. RNA Biol. 2013, 10, 1087–1092. [CrossRef] [PubMed]
149. Barturen, G.; Rueda, A.; Hamberg, M.; Alganza, A.; Lebron, R.; Kotsyfakis, M.; Shi, B.-J.; Koppers-Lalic, D.; Hackenberg, M. sRNAbench: Profiling of small RNAs and its sequence variants in single or multi-species high-throughput experiments. Methods Next Gener. Seq. 2014, 1, 21–31. [CrossRef]
150. Anders, S.; Huber, W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11, R106. [CrossRef] [PubMed]
151. Robinson, M.D.; McCarthy, D.J.; Smyth, G.K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26, 139–140. [CrossRef] [PubMed]
152. Tarazona, S.; Garcia-Alcalde, F.; Dopazo, J.; Ferrer, A.; Conesa, A. Differential expression in RNA-seq: A matter of depth. Genome Res. 2011, 21, 2213–2223. [CrossRef] [PubMed]
153. John, B.; Enright, A.J.; Aravin, A.; Tuschl, T.; Sander, C.; Marks, D.S. Human MicroRNA targets. PLoS Biol. 2004, 2, e363. [CrossRef] [PubMed]
154. Kertesz, M.; Iovino, N.; Unnerstall, U.; Gaul, U.; Segal, E. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39, 1278–1284. [CrossRef] [PubMed]
155. Sturm, M.; Hackenberg, M.; Langenberger, D.; Frishman, D. TargetSpy: A supervised machine learning approach for microRNA target prediction. BMC Bioinform. 2010, 11, 292. [CrossRef] [PubMed]
156. Wu, H.J.; Ma, Y.K.; Chen, T.; Wang, M.; Wang, X.J. PsRobot: A web-based plant small RNA meta-analysis toolbox. Nucleic Acids Res. 2012, 40, W22–W28. [CrossRef] [PubMed]
157. Bonnet, E.; He, Y.; Billiau, K.; Peer, Y.V.D. TAPIR, a web server for the prediction of plant microRNA targets, including target mimics. Bioinformatics 2010, 26, 1566–1568. [CrossRef] [PubMed]
158. Skinner, M.E.; Holmes, I.H. Setting up the JBrowse genome browser. Curr. Protoc. Bioinform. 2010. Chapter 9, Unit 9.13. [CrossRef]
159. Rueda, A.; Barturen, G.; Lebron, R.; Gomez-Martin, C.; Alganza, A.; Oliver, J.L.; Hackenberg, M. sRNAtoolbox: An integrated collection of small RNA research tools. Nucleic Acids Res. 2015, 43, W467–W473. [CrossRef] [PubMed]
160. Chen, X.; Liang, H.; Zhang, J.; Zen, K.; Zhang, C.Y. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 2012, 22, 125–132. [CrossRef] [PubMed]